Try our Advanced Search for more refined results
Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
- February 05, 2013 Mylan Says Unnamed Inventor Invalidates Merck Vytorin Patent
- May 19, 2011 CORRECTED: Mylan's Inequitable Conduct Claim Axed In Vytorin IP Suit
- August 23, 2010 Schering Goes After Impax Over Vytorin ANDA
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS